As part of the EHA conference, Prof Harry Iland launched the APML5 interim clinical trial results, a comparative bioavailability study of oral sodium hydrogen diarsenic tetroxide and intravenous [...]
Driven by our purpose ‘Better treatments…Better lives’, the ALLG is committed to improving the treatment, lives and survival rates of patients with blood cancers through clinical trial conduct. Working collaboratively with blood cancer specialists locally and internationally, our impact is profound.
Our membership includes more than 700 blood cancer specialists who are united by a common goal to find better ways to treat blood cancers through clinical trial conduct.
Help make a difference to the life of someone who has blood cancer. For patients and their loved ones, your donation means an improved chance of cure and better quality of life.
Gain access to cutting-edge, potentially life-saving new treatments before they’re widely available to the public. Many people with cancer are now living longer, with a better quality of life, due to clinical trials.